Abstract Details

Title A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 2 Trial of Intradermal Onabotulinumtoxin A Injections in the Treatment of Post Herpetic Neuralgia (PHN)

Topic Ethics, Pain and Palliative Care

Presentation(s) (-)

Poster/Presentation
Number 275

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Michael M. Tuchman, MD, FAAN (Palm Beach Neurological Center)	No disclosure on file
Alexandra S. Reynolds, MD	Dr. Reynolds has nothing to disclose.
	No disclosure on file
James P. Kesslak, PhD (Alzheon)	Dr. Kesslak has received personal compensation for serving as an employee of Alzheon.
	No disclosure on file
Rozalina Dimitrova, MD, MPH (Allergan, Inc)	No disclosure on file
Amanda VanDenburgh (Allergan)	No disclosure on file
Mitchell F. Brin, MD, FAAN (Abbvie / UC Irvine)	Dr. Brin has received personal compensation for serving as an employee of Allergan. Dr. Brin has stock in Allergan.
	No disclosure on file

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��